Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
clinical trials
deals
investing
2
×
life sciences
national blog main
san francisco blog main
akouos
amgen
astellas pharmaceuticals
boston
boston top stories
california institute for biomedical research
cancer
cancer drugs
cobimetinib
decibel therapeutics
fda
frequency therapeutics
harvard university
hearing loss
ipo
jeffrey karp
multiple sclerosis
national top stories
perceptive life sciences
regenerative medicine
revolution medicines
robert langer
roche
san francisco
san francisco top stories
sanofi
sensorineural hearing loss
taiwania capital management
the column group
the scripps research institute
third rock ventures
university of illinois
What
drug
2
×
ipo
2
×
medicines
affects
americans
approved
cancer
date
despite
developing
family
fda
frequency
hardest
hearing
hit
hottest
hunters
loss
meds
millions
plans
proteins
ras
reels
regenerative
research
revolution
targets
therapeutics
treat
Language
unset
Current search:
ipo
×
investing
×
drug
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
